Nalaganje...

PD-1/PD-L1 Blockade after Transient Lymphodepletion to Treat Myeloma

Early phase clinical trials targeting the programmed death receptor-1/ligand-1 (PD-1/PD-L1) pathway to overcome tumor-mediated immunosuppression have reported promising results for a variety of cancers. This pathway appears to play an important role in the failure of immune reactivity to malignant p...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kearl, Tyce J., Jing, Weiqing, Gershan, Jill A., Johnson, Bryon D.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3891840/
https://ncbi.nlm.nih.gov/pubmed/23616570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1202005
Oznake: Označite
Brez oznak, prvi označite!